Continuous Glucose Monitoring Devices Market is Anticipated to Witness High Growth Owing to Increase in Diabetic Population
![]() |
Continuous Glucose Monitoring Devices Market |
Continuous
glucose monitoring devices are medical devices used for continuous monitoring
of glucose levels in interstitial fluid by individuals with diabetes. It helps
in constant monitoring of glucose levels in body by transmitting real-time
glucose level signals to a receiver. The devices are minimally invasive and
provide real-time continuous information about glucose levels which can help in
better management of diabetes. The advantages of using these devices are
continuous tracking of glucose levels, avoiding spikes and dips in glucose
levels, alerting about changes and impending highs and lows. With rising
prevalence of diabetes worldwide due to obesity, sedentary lifestyle and
unhealthy diets, continuous monitoring is becoming important for effective
diabetes management.
The
Global continuous glucose monitoring devices market is estimated to be valued
at US$ 3.35 Bn in 2024 and is expected to exhibit a CAGR of 7.4% over the
forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Continuous
Glucose Monitoring Devices Market Demand are 3M , BSN Medical, Sigvaris
AG, Cardinal Health,Medi GmbH & Co, ArjoHuntleigh Healthcare India, Bio
Compression Systems Inc, Zimmer Biomet India, Spectrum Healthcare and Vissco
Healthcare. 3M is a frontrunner in developing accurate and easy to use
continuous glucose monitoring systems.
The key opportunities in the market include increasing focus on digital health
solutions, growing reimbursements for CGM devices and rising awareness about
diabetes management through continuous tracking. With technology advancements,
continuous monitoring devices are becoming compact, convenient to use and
affordable which is also driving their adoption globally.
There is high scope for global expansion of Continuous Glucose Monitoring
Devices market. In developed markets like North America and Europe, the
adoption rate of these devices is growing steadily driven by growing diabetic
population and favourable reimbursement policies. The emerging markets of Asia
Pacific and Latin America offer significant growth prospects for CGM devices
manufacturers due to increasing healthcare expenditure, large diabetic patient
pool and gradual awareness.
Market drivers:
- Growing prevalence of diabetes: With mounting cases of diabetes worldwide due
to sedentary lifestyle and obesity, there is increasing need for better
management of the disease. Continuous monitoring helps to keep diabetes under
control effectively.
- Technological advancements: Development of minimally invasive, compact and
affordable continuous glucose monitoring devices is a key driver. Integration
of these devices with smartphones enhances convenience.
Market restraints:
- High device costs: Continuous glucose monitoring systems are costly which
limits widespread adoption, especially in low and middle income countries.
- Reimbursement barriers: Full or partial reimbursement for CGM devices is
still not available in many countries restricting market growth. Only few
national insurance plans provide coverage.
Segment Analysis
The continuous glucose monitoring devices market can be segmented into
non-invasive devices and minimally invasive devices. Within non-invasive
devices, the flash glucose monitoring system segment currently dominates due to
its advantages over conventional self-monitoring blood glucose systems. These
include painless glucose monitoring and interstitial fluid measurement instead
of blood via a subcutaneous sensor.
Global Analysis
The North American region holds the largest share in the continuous glucose
monitoring devices market owing to rising prevalence of diabetes, increasing
obesity rates and growing geriatric population susceptible to chronic
illnesses. United States dominates North America due to higher healthcare
expenditures and developed reimbursement structure for diabetes management
devices. The Asia Pacific region is projected to exhibit the fastest growth
over the forecast period with China and India being the key emerging markets.
This can be attributed to improving access to healthcare facilities, rising
medical tourism and growing health awareness in developing countries of Asia
Pacific.
For more insights, Read- https://www.trendingwebwire.com/global-continuous-glucose-monitoring-devices-market-growth/
Comments
Post a Comment